The Influence of Psychedelics on Fundamental Beliefs and Mental Health

This cross-sectional, non-interventional survey study (n=1000) aims to investigate the effects of psychedelic experiences on fundamental beliefs and mental health in individuals who have used psychedelic substances.

This study is recruiting participants to explore the relationship between beliefs about free will and determinism, depression, and the use of psychedelics. Conducted by Charité Universitätsmedizin Berlin, Germany, under the lead of Dr. med. Michael Koslowski, the study is open to participants aged 18 years and above with experience in psychedelic drug use and sufficient English language skills.

The primary outcome focuses on assessing links between beliefs about free will, psychedelic experiences, and depression, while secondary outcomes include factors such as life satisfaction and meaning in life. Data collection involves an anonymous survey study conducted in English, with endpoints including various questionnaires and assessments related to beliefs, mental health, and psychedelic experiences. The study, planned to start on April 22, 2024, is expected to recruit 1000 participants and aims to publish its results in January 2025.

Topic Depression Personality Population Surveys
Country Germany
Visit trial

Trial Details



Trial Number

Sponsors & Collaborators

Charité – Universitätsmedizin Berlin
The MIND Foundation recently announced a partnership with Charité – Universitätsmedizin Berlin.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.